The Effects of Tormentic Acid and Extracts from Callistemon citrinus on Candida albicans and Candida tropicalis Growth and Inhibition of Ergosterol Biosynthesis in Candida albicans

Candida albicans and Candida tropicalis are the leading causes of human fungal infections worldwide. There is an increase in resistance of Candida pathogens to existing antifungal drugs leading to a need to find new sources of antifungal agents. Tormentic acid has been isolated from different plants including Callistemon citrinus and has been found to possess antimicrobial properties, including antifungal activity. The study aimed to determine the effects of tormentic and extracts from C. citrinus on C. albicans and C. tropicalis and a possible mode of action. The extracts and tormentic acid were screened for antifungal activity using the broth microdilution method. The growth of both species was inhibited by the extracts, and C. albicans was more susceptible to the extract compared to C. tropicalis. The growth of C. albicans was inhibited by 80% at 100 μg/ml of both the DCM: methanol extract and the ethanol: water extract. Tormentic acid reduced the growth of C. albicans by 72% at 100 μg/ml. The effects of the extracts and tormentic acid on ergosterol content in C. albicans were determined using a UV/Vis scanning spectrophotometer. At concentrations of tormentic acid of 25 μg/ml, 50 μg/ml, 100 μg/ml, and 200 μg/ml, the content of ergosterol was decreased by 22%, 36%, 48%, and 78%, respectively. Similarly, the DCM: methanol extract at 100 μg/ml and 200 μg/ml decreased the content by 78% and 88%, respectively. A dose-dependent decrease in ergosterol content was observed in cells exposed to miconazole with a 25 μg/ml concentration causing a 100% decrease in ergosterol content. Therefore, tormentic acid inhibits the synthesis of ergosterol in C. albicans. Modifications of the structure of tormentic acid to increase its antifungal potency may be explored in further studies.


Introduction
Fungal organisms of the genus Candida are the leading cause of yeast infections among humans. More than 17 Candida species are known to cause infection in human beings. Candida albicans is the most virulent and most predominant, causing about 90% of all invasive yeast infections followed by Candida tropicalis that causes about 7% of all yeast infections [1]. Infection by fungal pathogens of the genus Candida is commonly known as Candidiasis. Candidiasis commonly presents itself as mucocutaneous candidiasis in which lesions on the skin can be seen. Vaginal candidiasis results from the invasion of vaginal walls.
Candidiasis can also affect the mouth, a condition commonly known as oral thrush [2]. Fungal infections can lead to dysphagia, which is characterized by pain during swallowing due to infection of the esophagus. e proliferation of Candida can have catastrophic effects if the pathogenic fungi reach vital organs [3].
Candida species are opportunistic pathogens that cause candidiasis in humans [4]. ese organisms are referred to as opportunist pathogens as they constitute part of normal flora and generally do not cause any harm to immune-competent individuals. For immune-compromised individuals, however, infection by C. albicans and C. tropicalis among other pathogens can cause serious illness. In some cases, infection by these pathogens can even be fatal. Some of the predisposing factors for candidiasis include HIV and tuberculosis infection, cancer, diabetes, and the use of immune-suppressing drugs [5]. With the increasing cases of diseases, such as HIV, the incidence of invasive candidiasis has escalated over the past decades. e progression of Candida infection is dependent not only on the virulence factors but also on the host immune response [6]. Drugs have been formulated to treat Candida infections. ese drugs include azoles, polyenes, and allylamines [7]. Many of these available drugs target the ergosterol biosynthesis pathway that is unique to fungal membranes. Unfortunately, over the past decade, there has been a growing resistance of Candida species to these available drugs. It has become of importance to investigate other potential sources of antifungal agents. Plants can act as good sources of therapeutic phytochemicals [8].
Ergosterol is the major sterol found in fungal membranes. It was first isolated in 1889 by Charles Tanret from ergot [9]. Some of the physiological functions of ergosterol include maintaining membrane integrity and fluidity [10]. Fungal cells also require ergosterol for the completion of their cell cycle, a process known as the "sparkling function" [11]. In fungal cells, ergosterol also plays a role in mating. A study by Aguilar et al. [12] showed that ergosterol had an effect on the shape of the cell and that disruption of the cell figure affected the fusion of fungal cells during mating. e importance of this pathway is as a target for antifungal drugs is the fact that the biosynthesis of ergosterol occurs exclusively in fungal membranes.
Natural plant products are documented as rich sources of several compounds that may serve as scaffolds for the development of drugs with anti-Candida action [8,13]. Studies have shown that Callistemon citrinus has antimicrobial effects [14][15][16]. Several phytochemicals have been isolated from the plant including the pentacyclic triterpene and tormentic acid [17]. Tormentic acid is a triterpene found in a variety of plants. ough not extensively studied, some reports have been made about the anticancer and antimicrobial nature of this phytochemical [18,19]. Phytochemical studies on C. citrinus seem to also suggest that terpenoids including tormentic acid are responsible for the antifungal activity exhibited by its extracts [17]. To the best of our knowledge, no studies have been done to investigate the effect of tormentic acid on ergosterol biosynthesis. e study aimed to initially determine the effects of tormentic acid and extracts from C. citrinus on the growth C. albicans and C. tropicalis and to determine its effects on the synthesis of ergosterol in C. albicans.

Plant Collection and Preparation. Callistemon citrinus
leaves were collected from the University of Zimbabwe, Department of Biochemistry, Harare, Zimbabwe, latitude −17.7840, longitude 31.0530. e plant identity was authenticated and classified by Mr. Christopher Chapano, a taxonomist at the National Herbarium and Botanic Gardens (Harare, Zimbabwe). Leaves were separated and dried at a temperature of 50°C in an oven (Memmert, Schwabach, SRG, Germany) for three days. e dried leaves were ground to obtain a powder using a two-speed blender (Cole Parmer Instrument Company, Connecticut, USA), to optimise the solvent contact during the extraction. To each of the two plastic beakers, 50 g of the leaf powder was added. A 50 : 50 v/v solution of ethanol : water solvent solution was added to one beaker and the other, a 50 : 50 (v/v) solvent solution of dichloromethane (DCM) and methanol, was added. e two beakers were covered with foil paper and left to stand for 24 hours at room temperature with occasional swirling. Two filter papers (12.5 cm diameter, Sharkskin, 10347511, USA) were placed in two separate funnels and through one the ethanol: water extract was further filtered and to the other the DCM: methanol extract in solvent was filtered. ese were filtered into two well-labeled beakers. e two samples were left to dry for 10 days under a stream of air from a fan.

Isolation of Tormentic Acid Using Column
Chromatography.
e extract was run on a column with 100% hexane initially as the eluting solvent. Batch gradient system column elution was employed starting with a solvent of low polarity to that with high polarity. e batch gradient system was a 20-step gradient elution with a gradual increase of polarity. Polarity on the column was increased by introducing a polar solvent, to hexane up to a solvent system with 100% ethyl acetate. Methanol was added to 100% EA up to 90% EA and 10% methanol. Fractions of 250 ml were collected and concentrated using a Buchi RII rotary evaporator (Buchi R2, BÜCHI Labortechnik AG, Flawil, Switzerland).
in layer chromatography was used for the analysis of the collected fractions. e fractions, which came out having the same Rf values, were pooled. e pooled fractions were left to evaporate to dryness for crystals to form. Purification of the pooled fractions was performed by washing away the impurities. Single spots observed on the developed chromatograms under UV (354 and 365 nm) after staining with sulphuric acid were deemed pure and were subjected to NMR/MS analyses.  13 C, CD 3 OD at 49.0 ppm). 2D NMR experiments were run using standard pulse sequences. Molecular formulae were determined by electrospray ionisation with a 7-T hybrid ion trap and a TOF detector running in positive or negative mode. One of the isolates was identified as tormentic acid based on NMR data and similar data in the literature ( Figure 1). e cell concentrations were standardised using 0.5 M MacFarland solution to 2 × 10 8 c.f.u/ml according to protocol by Ramirez-Arcos [19]. e broth microdilution assay was conducted to determine the effect of the two crude extracts and pure tormentic acid on both C. albicans and C. tropicalis according to Wiegand et al. [20]. Double dilution concentrations of 0 μg/ml to 100 μg/ml of the extract and tormentic acid were prepared in SDB. Fluconazole or miconazole was used as the positive control. Wells containing either the extract only or SDB only served as controls. e 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was done to investigate the presence/absence of viable cells in all wells after incubation according to [21]. A volume of 20 μl of the MTT solution was added to each of the 96 wells on the microtitre plates. e plates were incubated at 37°C for at least 2 hours. Color changes were quantified at 590 nm using a microplate reader (Genios Pro, Tecan Group Ltd., Grödig, Austria). e Minimum inhibitory concentrations (MIC) for the extract or tormentic acid were recorded. Graphs were plotted to show cell viability using GraphPad Prism6 (Version 6.0 GraphPad Software Inc., San Diego, California, USA).

Determination of Ergosterol after Exposure to Extracts and
Tormentic Acid. Determination of the amount of ergosterol was done according to the method by Arthington-Skaggs et al. [22] with slight modifications. Candida cells were grown on Sabouraud dextrose agar (SDA). e cells were subcultured in 20 ml of SDB and incubated for 24 hours at 37°C in a Mini Incubated Shaker (Lab Doctor ™ , MidSci Co, St. Louis, North America). e working solutions for DCM: methanol extract and for tormentic acid were 200 μg/ml, 100 μg/ml, 50 μg/ml, and 25 μg/ml. e working concentrations for miconazole (positive control) were 25 μg/ml, 12.5 μg/ml, 6.3 μg/ml, and 3.1 μg/ml. e negative control had the cell culture and media. ese solutions were incubated for 24 hours at 37°C with shaking at 170 rpm. After incubation, the solutions were centrifuged at 2 700 rpm for 5 minutes in a Rotofix centrifuge (Taufkirchen, Germany). e cells were washed with distilled water and the net weight of the cells was recorded. A volume of 3 ml 25% alcoholic potassium hydroxide was added to each of the Candida pellets and mixed for one minute. e cell suspensions were then transferred to clean borosilicate glass tubes and incubated at 85°C for an hour. e cells were left to cool at room temperature. A solvent mixture of sterile water and nhexane (1 : 3 v/v) was added to each of the cell suspensions.
e mixture was vortexed for 3 minutes. e clear hexane layer was drawn out and transferred to a clean tube and stored at −20°C. e hexane extract was diluted in ethanol (1 : 4 v/v) and scanned at 220 nm and 300 nm using a UV/ VIS spectrophotometer (Biobase BK D560, Jinan, Shandong, China). e amount of ergosterol was calculated as the difference in absorbance between the 230 nm and the 281.5 nm peak per unit mass of the fungal cell pellet using the following equation: where A 281.5 is the absorbance of hexane extract at 281.5 nm, A 230 is absorbance between 230 nm and 281.5 nm, F is the dilution factor of hexane extract in ethanol, and 290 and 518 are extinction values determined for crystalline ergosterol.

Statistical Analyses.
All data in this study were analysed using GraphPad prism software, versions 7 and 8 (GraphPad Software Inc., San Diego, California, USA). Statistical analysis of data was done using one-way analysis of variance (one-way ANOVA) followed by Dunnett's test for multiple comparisons. Tests for antifungal susceptibility of Candida to crude extracts and miconazole were done in

Sample Preparation and Yields of Extraction of the Crude
Extract. e mass of the extracts obtained from 50 g of leaf extract in 100 ml of solvent solution was weighed after drying. e ethanol: water extract and the DCM: methanol crude extract yields 4.8 g (9.2%) and 1.6 g (3.2%) of powdered extract, respectively.

Screening for Antifungal Effects of the Extract and Tormentic Acid on C. albicans.
ere was a general decrease in cell density with an increase in ethanol: water extract concentration and the DCM: methanol extract concentration from 0 μg/ml to 100 μg/ml for both species of Candida ( Figure 5). e highest cell density was recorded in cells with the control that contained cells with no exposure to any test compound. e lowest cell density was recorded in wells containing 100 μg/ml of the ethanol: water extract and the DCM: methanol extract with a percentage inhibition of 80%. e ethanol: water extract and the DCM: methanol extracts reduced the growth of C. tropicalis by 15% and 35%, respectively, at 100 μg/ml ( Figure 6). ere was no growth of cells observed in the SDB media only wells. Tormentic acid reduced the growth of C. albicans and C. tropicalis by 72% and 28%, respectively, at 100 μg/ml (Figure 7). Miconazole significantly reduced the growth of both species with MICs of 1.6 μg/ml and 12.5 μg/ml for C. albicans and C. tropicalis, respectively.

Ergosterol Quantification after Exposure to Extracts and
Tormentic Acid. Using a UV/Vis scanning spectrophotometer (Biobase, Jinan, Shandong, China), sterols extracted with hexane were scanned within the wavelength range of 200 nm to 300 nm. e absorption spectra for ergosterol extracted from cells exposed to varying concentrations of tormentic acid and miconazole are shown in Figures 8 and 9 , respectively.
Percentage decreases in ergosterol were calculated relative to ergosterol content in unexposed cells. ese data are summarised in Figure 10 for the cells exposed to the DCM: methanol extract and tormentic acid. e percentage decrease in ergosterol for cells exposed to miconazole is shown in Figure 11. e highest concentration of DCM: methanol extract (200 μg/ml), tormentic acid (200 μg/ml), and miconazole (25 μg/ml) gave 87.5%, 78.5%, and 100% inhibition of ergosterol content, respectively.

Discussion
e therapeutic properties of C. citrinus are attributed to the presence of active phytochemicals found in the plant leaves, flowers, stems, bark, and roots [26]. e amount and composition of phytochemicals depend on the plant part, from which the phytochemicals are obtained [27,28]. Extraction of phytochemicals, in this study, was done from the leaves of the C. citrinus. Antifungal susceptibility tests on C. albicans showed significant inhibition of fungal growth by C. citrinus extracts. e percentage inhibition at the highest concentration investigated was compared for all treatments with the cells only readings being used as reference points. C. albicans was more susceptible to tormentic acid and the two crude extracts than C. tropicalis. e DCM: methanol extract generally showed higher antifungal effects on both C. albicans and C. tropicalis when compared to tormentic acid and the water: ethanol extract. For tests on C. tropicalis, however, generally lower levels of cell growth inhibition were observed compared to C. albicans. C. albicans was, therefore, more susceptible and the DCM: methanol extract was the most potent antifungal extract, and for this reason, further studies were carried out using C. albicans only. Several mechanisms may attribute to the effect brought about by natural products. ese include alteration of the membrane permeability, disruption of biological processes that are important for the microorganism, like the synthesis of ergosterol an essential component of the fungal membrane [29], disruption of the growth mechanism of microbe, and alterations in the respiratory chain [30]. e extracts generally showed higher antifungal activity than tormentic acid. is may have been due to the synergistic effects of phytochemicals within the crude extracts. e DCM: methanol extract showed more potency against the fungal strains. is may be due to higher concentrations of some specific antifungal biomolecules within this extract as the DCM: methanol extract can extract nonpolar and polar substituents from C. citrinus leaves. e nonpolar active secondary metabolites including tormentic acid or their combined activity with other polar phytochemicals may be responsible for the relatively higher antifungal activity in the ethanol: water extract [31]     Cell density @ 590 nm Figure 6: e effect extracts from C. citrinus on C. tropicalis. Percentage inhibition of 15% and 35% was observed at 100 μg/ml of the ethanol: water extract and DCM: methanol extract, respectively. e data shown in this graph represent the mean for four replicates. ese data were analysed using one-way ANOVA followed by Dunnett's test for multiple comparisons, comparing means to the negative control (SDB).   C. tropicalis (b). e graph shows a dose-dependent decrease in cell density as the concentration of tormentic acid was increased. Percentage inhibition of 72% and 28% was observed at 100 μg/ml for C. albicans and C. tropicalis, respectively. ese data represent a mean of four replicates. e data were analysed by one-way ANOVA and Dunnett's test for multiple comparisons. Mean values were statistically compared to the negative control (SDB). Error bars indicate standard deviation; * * * * p < 0.00001.  Figure 8: Absorbance spectra of ergosterol from C. albicans cells exposed to tormentic acid. Cell pellets of C. albicans were exposed to 25 μg/ ml, 50 μg/ml, 100 μg/ml, and 200 μg/ml of tormentic acid (TA). e graphs show the UV/Vis scan of the extracted sterols from 200 nm to 300 nm. ere was a similar spectra pattern, and a general decrease with increased concentration of tormentic acid was observed. e Scientific World Journal 7 have been carried out to determine the underlying cause of the lack of susceptibility of C. tropicalis strains to antifungal agents. One of the extensively studied areas is the change in the azole target that is the enzyme lanosterol C14α demethylase or CYP 51. ese studies have shown mutations in the amino acid sequence of CYP 51 enzyme. Some of the most common mutations discovered were in Y132F, S154L, and K143R amino acid residues, which are found within the active site of the enzyme [36,37]. is change in amino acid sequence could result in reduced binding capacity of azole drugs and even other antifungal agents, such as the tested tormentic acid as well as extracts. Wavelength (nm) Figure 9: Absorbance spectra of ergosterol from C. albicans cells exposed to miconazole. Cell pellet was exposed to miconazole concentrations of 3.125 μg/ml, 6.25 μg/ml, 12.5 μg/ml, and 25 μg/ml of miconazole (M). e graphs show the UV/Vis scan from 200 nm to 300 nm. * * * * * * * * * * * * * * e Scientific World Journal C. albicans was shown to be more susceptible to C. citrinus extracts when compared to C. tropicalis, and, therefore, it was used in the subsequent ergosterol biosynthesis investigation assay. e cells were treated with varying concentrations of tormentic acid, and ergosterol production was monitored. e effect of DCM: methanol extract that showed the highest antifungal effect on C. albicans was also investigated. e results showed that the concentration of extracts was directly proportional to the amount of ergosterol per unit mass of C. albicans cells. For concentrations of 25 μg/ml, 50 μg/ml, 100 μg/ml, and 200 μg/ml of tormentic acid, the percentage decrease in ergosterol was 21.9%, 35.7%, 48.2%, and 78.5%, respectively. e same concentrations of DCM: methanol extract gave a percentage decrease of 19.7%, 53.2%, 78.4%, and 87.5%. e percentage decrease in ergosterol content was relatively higher than tormentic acid with DCM: methanol treatment. e effect of miconazole on ergosterol biosynthesis in C. albicans was determined at concentrations 3.125 μg/ml, 6.25 μg/ml, 12.5 μg/ml, and 25 μg/ml. e percentage decreases in these tests were 20.0%, 61%, 98.2%, and 100%, respectively. Ergosterol synthesis in miconazole treated cells was almost completely inhibited at  Figure 11: e effects of miconazole on cells exposed to miconazole. Ergosterol content decreased as the concentration of miconazole was increased. A percentage decrease in ergosterol of 100% was observed at 25 μg/ml of miconazole. Data were analysed by one-way ANOVA. e data represent the mean of two experiments, and the standard deviation was shown by the error bars. * * * * p < 0.0001 and * * p < 0.01.

Erg8
Dimethylalyl-PP Erg19 Geranyl-P Idi 1 Farnesyl-PP  Figure 12: e ergosterol biosynthetic pathway. e pathway has been divided into three subpathways, the mevalonate pathway, the late pathway, and the alternative pathway, which can occur in the event of inactivation of lanosterol metabolizing enzymes. Shown in red are some common types of antifungal drugs at their site of action within this pathway adopted from [41]. e Scientific World Journal 12.5 μg/ml of miconazole, which was the MIC obtained in the susceptibility tests. is finding also corresponds with the findings by other authors [38]. Bhattacharya et al. [39] reported the MIC of miconazole to be within the range of 0.2 μg/ml to 25 μg/ml against 20 C. albicans strains. e decrease in extracted ergosterol with increasing tormentic acid and DCM: methanol extract concentration may suggest that these C. citrinus phytochemicals impair the synthesis of ergosterol [40]. Available pharmaceutical drugs also use inhibition of ergosterol biosynthesis as a therapeutic mode of action ( Figure 12). Azole drugs, in particular, inhibit the synthesis of ergosterol by binding to CYP 51 enzyme responsible for the demethylation of its sterol substrate, lanosterol [42]. e enzyme structure of CYP 51 is highly conserved in fungal cells, and mainly the heme iron within its porphyrin ring as well as amino acid sequences within the enzyme's active site governs its catalytic activity. Tyrosine residues and two weak hydrogen bonds hold the heme uniquely. His 310 and Asp 226 in the I and F helix, respectively, are involved in proton delivery. Within the I helix of the CYP fold, r 311 also plays an important role in the binding of substrates and inhibitors close to the iron group [43]. e higher antifungal potency of the DCM: methanol extract as compared to tormentic acid could be attributed to the various bioactive phytochemicals within this crude extract. e crude extract could contain one or more secondary metabolites that have antifungal activity. e combinations of phytochemicals within this crude extract including tormentic acid may have additive or synergic effects on the impairment of ergosterol biosynthesis in C. albicans [31]. It is also possible that some of the phytochemicals within the crude extract have much higher antifungal activity, but the presence of tormentic acid and other phytoconstituents leads to an antagonistic effect where antifungal potency is reduced. Researchers have been able to isolate some biomolecules from C. citrinus that showed higher antifungal activity. e findings by Dakole et al. [44] show that essential oils of C. citrinus have fungicidal activity, with recorded MIC values of less than or equal to 6.25 μg/ml. Rao et al. [45] found that isolated terpene, carvacrol, possessed antifungal activity, and the MIC of carvacrol was found to be 79.8 μg/ml. Another study on terpene antifungal activity has also suggested the synergic activity of terpene within plant extracts [46]. Although isolation and characterization of phytochemical content were not carried out in this study, based on studies by other researchers, secondary metabolites present in the DCM: methanol extract would have caused the observed effects [14,47].
Lanosterol metabolism involves the oxidation of the 14αmethyl group of lanosterol and subsequent demethylation of this group. e resemblance of tormentic acid structure to the conventional substrate of CYP51, lanosterol, may suggest similar interactions with this enzyme. Tormentic may be acting as a competitive inhibitor of CYP 51, thereby, reducing the activity of the enzyme on lanosterol per unit time. As tormentic acid also possesses a 14α-methyl carbon, it is possible that the enzyme competitively interacts with tormentic acid through demethylation [48].
It has also been reported that terpenes possess antifungal properties. ese studies seem to suggest that the hydroxyl group and aromatic groups are important for antifungal activity [45]. Terpenes have also been shown to bind to CYP 51 by type 1 spectral binding which mimics the binding of lanosterol to CYP 51. Miconazole was able to completely inhibit ergosterol synthesis at 25 μg/ml. is high potency maybe because miconazole, as with other azole drugs, binds directly to the heme group of CYP 51, thereby effectively inhibiting the action of this enzyme [43].
Ergosterol is present in cells in the form of free ergosterol, which carries out important functions in the cell membrane, as well as its esterified storage form. e esterified form of ergosterol is present in the cytosol [49]. In order, therefore, to extract all ergosterol synthesized by fungal cells, an initial saponification step was employed. Saponification was carried out by treating fungal pellets with alcoholic KOH and subjecting these cells to a high temperature of 80°C [50]. In so doing, fatty acid conjugates of ergosterol, as well as other lipids, such as phospholipids and triglycerides, are broken down [51].
For the extraction of ergosterol, n-hexane was used as a solvent as it has been proven to be a suitable solvent for sterol extraction [52].
is extraction solvent owes its sterol extracting capacity to its nonpolar nature and is recommended due to its low latent heat of vaporisation [53]. e solvent extracts ergosterol along with other nonpolar substances from the cells. ese give the difference absorbance values obtained. Due to differences in chemical structures, different components within the samples have different absorption properties at different wavelengths within the electromagnetic spectrum. An intense spectrum for ergosterol, together with dihydroergosterol, is observed at 230 nm. Unfortunately, no independent peak for ergosterol on its own has been observed in previous studies. e quantification of ergosterol, therefore, was calculated as the difference in absorbance at 230 nm and that at 281.5 nm, where dihydroergosterol independently gives maximum absorbance [22].

Conclusion
C. albicans was more susceptible to tormentic acid and extracts of C. citrinus as compared to C. tropicalis. Extracts had more cytotoxic effects against Candida cells than tormentic acid. e DCM: methanol extract had the highest inhibitory potency against Candida cells. Tormentic acid significantly reduced the levels of ergosterol in C. albicans. e DCM: methanol extract reduced ergosterol significantly compared to tormentic acid. is may suggest synergistic effects of tormentic acid and other active compounds within the crude extract. Tormentic acid, therefore, has inhibitory effects against Candida cells, and the mode of action used by tormentic acid is ergosterol biosynthesis inhibition. A work published previously [54] reported the inhibition of protease production in Staphylococcus aureus by extracts from C. citrinus and tormentic acid. us, the current findings add on to the board of knowledge that tormentic acid and extracts from C. citrinus may be exploited for the development of antifungal agents, which also have antibacterial agents.
Data Availability e datasets generated during and/analysed during the current study are available from the corresponding author on reasonable request. Disclosure e authors alone are responsible for the content and writing of the paper.

Conflicts of Interest
e authors declare that there are no conflicts of interest regarding the publication of this paper.